NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002060

Registered date:10/06/2009

The Influence of Proton Pump Inhibitors on the Antiplatelet Effect of Clopidogrel

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedischemic heart disease
Date of first enrollment2009/06/01
Target sample size120
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)the change of administration from 20 mg of omeprazole to 10 mg of rabeprazole the change of administration from 10 mg of rabeprazole to 20 mg of omeprazole control

Outcome(s)

Primary OutcomeMaximal Platelet Aggregation Rate after intake of PPI
Secondary Outcome

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1) contraindicative patients of aspirin and clopidogrel, 2) patients with warfarin, 3) patients with thrombolytic therapy within 2 weeks, and 4) patients taking ticlopidine, cilostazole or dipyridamole within 1 month

Related Information

Contact

public contact
Name Toshikazu Jinnai
Address 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507 Japan
Telephone 075-751-4255
E-mail
Affiliation Kyoto University Department of Cardiovascular Medicine
scientific contact
Name Takeshi Kimura
Address 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507 Japan
Telephone 075-751-4254
E-mail
Affiliation Kyoto University Department of Cardiovascular Medicine